Changes in interferon-γ release assay readout after COVID-19 vaccination: A prospective cohort study | Zendy

Nan-Yu Chen | Zendy; ZhuoHao Liu | Zendy; ShuWei Kao | Zendy; Huang-Shen Lin | Zendy; IngKit Lee | Zendy; Jun-Yuan Zheng | Zendy; Ssu-Wei Wang | Zendy; YuHsiang Hsiao | Zendy; Hui-Chin Lin | Zendy; TingShu Wu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Changes in interferon-γ release assay readout after COVID-19 vaccination: A prospective cohort study

Author(s) -

Nan-Yu Chen,

ZhuoHao Liu,

ShuWei Kao,

Huang-Shen Lin,

IngKit Lee,

Jun-Yuan Zheng,

Ssu-Wei Wang,

YuHsiang Hsiao,

Hui-Chin Lin,

TingShu Wu

Publication year - 2022

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2022.06.044

Subject(s) - medicine , vaccination , interferon gamma release assay , prospective cohort study , covid-19 , interferon gamma , immunology , tuberculosis , mycobacterium tuberculosis , latent tuberculosis , pathology , cytokine , disease , infectious disease (medical specialty)

Interferon-γ release assays (IGRAs) are widely used in public health practice to diagnose latent tuberculosis. During the COVID-19 pandemic and rollout of COVID-19 vaccination, it has remained unclear whether COVID-19 vaccines interfere with IGRA readouts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research